| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs141772093 |
chr5:179818129-179818130 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 2 |
rs551458173 |
chr5:179818180-179818181 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs6601120 |
chr5:179818199-179818200 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 4 |
rs561691620 |
chr5:179818207-179818208 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs4700949 |
chr5:179818208-179818209 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 6 |
rs6601121 |
chr5:179818227-179818228 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs542089104 |
chr5:179818234-179818235 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs147196448 |
chr5:179818257-179818258 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs527589618 |
chr5:179818269-179818270 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs371712954 |
chr5:179818294-179818295 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs6601122 |
chr5:179818333-179818334 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 12 |
rs190226138 |
chr5:179818440-179818441 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs140463384 |
chr5:179818462-179818463 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs181564222 |
chr5:179818484-179818485 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs370532696 |
chr5:179818492-179818493 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs533341636 |
chr5:179818501-179818502 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs375276933 |
chr5:179818515-179818516 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs79484757 |
chr5:179818516-179818517 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs185859710 |
chr5:179818542-179818543 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs570160902 |
chr5:179818548-179818549 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs565991830 |
chr5:179818551-179818552 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs535002543 |
chr5:179818556-179818557 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs75091672 |
chr5:179818568-179818569 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs147482994 |
chr5:179818569-179818570 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs370115802 |
chr5:179818590-179818591 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs374335066 |
chr5:179818598-179818599 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs114581961 |
chr5:179818618-179818619 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs74450946 |
chr5:179818654-179818655 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs576105746 |
chr5:179818681-179818682 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs569145526 |
chr5:179818687-179818688 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs536116073 |
chr5:179818719-179818720 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs139274950 |
chr5:179818745-179818746 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs566047828 |
chr5:179818747-179818748 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs368734835 |
chr5:179818761-179818762 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs78941711 |
chr5:179818776-179818777 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs541307900 |
chr5:179818834-179818835 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs535044475 |
chr5:179818846-179818847 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs116699545 |
chr5:179818853-179818854 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs149979604 |
chr5:179818864-179818865 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs7733582 |
chr5:179818868-179818869 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 41 |
rs7719158 |
chr5:179818920-179818921 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 42 |
rs537551851 |
chr5:179818921-179818922 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs76759969 |
chr5:179818927-179818928 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs201615679 |
chr5:179818937-179818938 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs34937381 |
chr5:179818938-179818939 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs77910584 |
chr5:179818941-179818942 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs549130487 |
chr5:179818943-179818944 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs559543485 |
chr5:179818946-179818947 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs528688815 |
chr5:179818950-179818951 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs190272948 |
chr5:179818955-179818956 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|